Here’s why I think that $MRK buys $JANX soon.
$Merck & Co (MRK.US)$ already has an active partnership with $Janux Therapeutics (JANX.US)$ for two TRACtr targets, and CEO Davis has evinced a preference for acquisition of $SPDR S&P Biotech ETF (XBI.US)$ in which $Merck & Co (MRK.US)$ already has a seat at the table.
$Merck & Co (MRK.US)$ acquisition of $HARP earlier this year (for a song) shows their interest in the T Cell engager space, and PSMA targeting lead candidate would provide $Merck & Co (MRK.US)$ entree to a target/indication which they don’t yet have a presence. So, like $HARP with DLL3, not first in class, but a molecule that “could do something interesting”.
Suspect many interested suitors in $Janux Therapeutics (JANX.US)$ , to CEO Davis’ comment re: asset Haves and Have nots.
Bloomberg, then Betaville.
I think that negotiations have been taking some time, and with share price creeping up, $MRK takes an initial stake from $Janux Therapeutics (JANX.US)$ insiders, buying some more time by introducing downward share price pressure by the very public insider sale — again, it was a huge block…
These things take time, but $MRK has its mark on $JANX, I believe…
![Here’s why I think that $MRK buys $JANX soon.](https://ussnsimg.moomoo.com/sns_client_feed/70042928/20240625/750b4fcf98214be092e9b34e13929e22.png/big?area=100&is_public=true)
![Here’s why I think that $MRK buys $JANX soon.](https://ussnsimg.moomoo.com/sns_client_feed/70042928/20240625/39105dc83204470bb4f3acbd4a5c4741.png/big?area=100&is_public=true)
![Here’s why I think that $MRK buys $JANX soon.](https://ussnsimg.moomoo.com/sns_client_feed/70042928/20240625/aa308ce61fe84704848ba9495e8c6769.png/big?area=100&is_public=true)
![Here’s why I think that $MRK buys $JANX soon.](https://ussnsimg.moomoo.com/sns_client_feed/70042928/20240625/af07a54f0847430fbfa8dd548d87cf82.png/big?area=100&is_public=true)
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment